Oncology

Nivolumab shows promise in patients whose disease progressed after ipilimumab and BRAF inhibitor therapy.

Catch up with the latest developments in cancer research.

Weight cycling may influence the biological processes that can lead to cancer.

Process improves the accuracy of cancer treatments.

High cost of research and development causes less investment by pharmaceutical firms.

Researchers predict the progression of the cancer based on its expression of IL13RA2.

Active surveillance increases in prevalence.

Study finds significant barriers to health care access, including stigmatization.

A lymphotoxin-beta receptor inhibitor may stop the spread of the disease.

Studies show inexpensive, generic drugs can help reduce breast cancer mortality in postmenopausal women.

Long-term survival results after 5 years of ipilimumab therapy in patients with advanced melanoma shows promise.

Novel oral soluble film is indicated to prevent highly and moderately emetogenic chemotherapy-induced nausea and vomiting.

Toradol may limit ability of tumor cells to grow and spread.

Toxin may inhibit cell division in cancerous cells.

Results of the long-awaited Keynote 006 study prove the superiority of pembrolizumab to ipilimumab on criteria of both progression-free survival and overall survival.

Destabilized cell metabolism can lead to the creation of tumors.

Contamination with particulate matter can lead to inflammation, allergic reaction, and blood vessel blockage.

Iressa blocks the activity of an enzyme responsible for regulating pathways implicated in the growth and survival of cancer cells.

Heat shock protein inhibitors may stop proteins involved in cancer cell survival.

Amino acid abundant in meat and fish could open receptors in cancer cells.

Particles are surrounded by a protective coating to release drugs in the presence of a specific tumor enzyme.

Pharmacists will need to evaluate several new factors when selecting and dispensing products.

Colonoscopy can catch tumors in a more treatable stage.

Sonidegib treats adult patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy.

Researchers explore potential of sunscreens with cancer-preventive properties.

Silver is a useful element to prevent bacterial growth.

Study finds less than half of cancer patients have a completed will.

Doxorubicin can be safely omitted in treatments for Wilms' tumor patients deemed least likely to relapse.